chr12-865122-C-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_213655.5(WNK1):c.2152C>T(p.Arg718Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,519,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R718H) has been classified as Uncertain significance.
Frequency
Consequence
NM_213655.5 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary sensory and autonomic, type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
- pseudohypoaldosteronism type 2CInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hereditary sensory and autonomic neuropathy type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WNK1 | ENST00000340908.9 | c.2152C>T | p.Arg718Cys | missense_variant | Exon 9 of 28 | 5 | NM_213655.5 | ENSP00000341292.5 | ||
WNK1 | ENST00000315939.11 | c.2139+2852C>T | intron_variant | Intron 8 of 27 | 1 | NM_018979.4 | ENSP00000313059.6 |
Frequencies
GnomAD3 genomes AF: 0.0000341 AC: 5AN: 146764Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000490 AC: 6AN: 122564 AF XY: 0.0000452 show subpopulations
GnomAD4 exome AF: 0.0000321 AC: 44AN: 1372342Hom.: 0 Cov.: 30 AF XY: 0.0000326 AC XY: 22AN XY: 675438 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000341 AC: 5AN: 146764Hom.: 0 Cov.: 32 AF XY: 0.0000279 AC XY: 2AN XY: 71682 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
- -
WNK1: PM2, BP4 -
Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:2
- -
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 718 of the WNK1 protein (p.Arg718Cys). This variant is present in population databases (rs786205473, gnomAD 0.01%). This missense change has been observed in individual(s) with limb-girdle weakness (PMID: 27671536). ClinVar contains an entry for this variant (Variation ID: 191028). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt WNK1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The p.R718C variant (also known as c.2152C>T), located in coding exon 9 of the WNK1 gene, results from a C to T substitution at nucleotide position 2152. The arginine at codon 718 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been detected in an individual with limb-girdle muscular dystrophy (Monies D et al. Hum Genomics, 2016 Sep;10:32). This amino acid position is well conserved in available vertebrate species; however, cysteine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at